Jenny C. Chang, MD, director of the Methodist Cancer Center at Houston Methodist Hospital, discusses genomic testing in breast cancer.
Jenny C. Chang, MD
Advertisement
Articles by Jenny C. Chang, MD
Dr. Jenny Chang, from the Methodist Cancer Center, Discusses Combining HER2 Targeted Therapies
Advertisement
Latest Updated Articles
Dr. Chang on Genomic Testing in Breast CancerJanuary 25th 2017
Dr. Chang on Combining HER2 Targeted TherapiesMarch 22nd 2012
Advertisement
Advertisement
Trending on OncLive
1
FDA Finalizes 3 Guidance Documents to Broaden Cancer Clinical Trial Eligibility Criteria
2
Dr Le on Choosing Between Zongertinib and Sevabertinib in HER2 TKD–Mutant NSCLC
3
Innovative Screening Approaches, Targeted Therapies, and Team-Based Care Drive Head and Neck Oncology Advances
4
AI Tools Show Early Promise Across Drug Discovery, Clinical Decision-Making in Lung Cancer
5